Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2000
06/29/2000CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000CA2356215A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355704A1 Melatonin derivatives and medicine containing same
06/29/2000CA2355630A1 Compounds useful in the treatment of inflammatory diseases
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/28/2000EP1013660A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012321A2 Viral infection of cells using viral vectors
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012296A2 Mammalian thioredoxin
06/28/2000EP1012285A1 Beta-defensins
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012261A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012142A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
06/28/2000EP1011743A1 Loading and release of water-insoluble drugs
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011698A1 Chemical supplementation of bone
06/28/2000EP1011658A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
06/28/2000EP1011654A1 A method of modulating cellular activity
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011636A1 New foam-forming pharmaceutical composition
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000EP0639224B1 Lectin domain variants of selectin
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1257733A Medical capsule for treating rheumatoid arthritis
06/28/2000CN1257715A Tincture for treating rheumatoid arthritis and its preparing process
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/27/2000US6080878 Method of preparing 16-dehydro vitamin D compounds
06/27/2000US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases
06/27/2000US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction
06/27/2000US6080782 Cyclohexyl dihydrobenzofuranes
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080763 Inhibit the release of inflammatory cytokines, e.g., tumor necrosis factor and interleukin-1; useful to treat chronic inflammatory disease; autoimmune diseases, e.g. rheumatoid arthritis, osteoporosis; pyrazolylureas
06/27/2000US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000US6080739 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity
06/27/2000CA2013960C Substituted dibenzofurans and methods of using same
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000035956A1 Antihuman vegf monoclonal antibody
06/22/2000WO2000035952A2 Compounds for control of eating, growth and body weight
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035921A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035436A2 Treatment of arthritis with mek inhibitors
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000WO2000015244A3 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354591A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000CA2354510A1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354402A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2346448A1 Treatment of arthritis with mek inhibitors
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000CA2289422A1 Process and intermediates for preparing 5-lipoxygenase inhibitors
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009829A1 Adipocyte-specific protein homologs
1 ... 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 ... 1272